Neuromuscular and cardiac adverse events associated with immune checkpoint inhibitors: pooled analysis of individual cases from multiple institutions and literature

BACKGROUND: Immune checkpoint inhibitors (ICIs) have revolutionized the management of multiple tumors, due to improved efficacy, quality of life, and safety. While most immune-related adverse events (irAEs) are mild and easily managed, in rare cases such events may be life-threatening, especially th...

Descripción completa

Detalles Bibliográficos
Autores principales: Boutros, A., Bottini, A., Rossi, G., Tanda, E.T., Spagnolo, F., Barletta, G., Croce, E., Fava, P., Parisi, A., De Rosa, F., Palla, M., Marconcini, R., Ferrari, M., Grandis, M., Spallarossa, P., Sarocchi, M., Arboscello, E., Del Mastro, L., Lambertini, M., Pronzato, P., Genova, C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9958259/
https://www.ncbi.nlm.nih.gov/pubmed/36791639
http://dx.doi.org/10.1016/j.esmoop.2023.100791

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9958259/
https://www.ncbi.nlm.nih.gov/pubmed/36791639
http://dx.doi.org/10.1016/j.esmoop.2023.100791

Ejemplares similares